COVINO, Elvio
 Distribuzione geografica
Continente #
AS - Asia 833
NA - Nord America 199
EU - Europa 125
OC - Oceania 6
SA - Sud America 5
AN - Antartide 1
Totale 1.169
Nazione #
SG - Singapore 678
US - Stati Uniti d'America 189
CN - Cina 75
HK - Hong Kong 58
GB - Regno Unito 54
CZ - Repubblica Ceca 30
DE - Germania 16
IN - India 13
IT - Italia 10
CA - Canada 9
AU - Australia 6
BR - Brasile 3
FR - Francia 3
NL - Olanda 3
UA - Ucraina 3
FI - Finlandia 2
ID - Indonesia 2
JP - Giappone 2
TR - Turchia 2
AR - Argentina 1
BD - Bangladesh 1
BE - Belgio 1
CL - Cile 1
ES - Italia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IL - Israele 1
MX - Messico 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
YE - Yemen 1
Totale 1.169
Città #
Singapore 68
Ashburn 63
Hong Kong 58
London 52
Boardman 43
Hefei 40
Brno 27
Shanghai 22
Pune 9
Santa Clara 9
Los Angeles 8
Toronto 8
Munich 7
Council Bluffs 6
San Francisco 6
Washington 6
Seattle 5
Canberra 3
Guangzhou 3
Olomouc 3
Amsterdam 2
Helsinki 2
Melbourne 2
North Liberty 2
Rome 2
Striano 2
São Paulo 2
Tokyo 2
Wuhan 2
Bratislava 1
Brussels 1
Chengdu 1
Chicago 1
Las Vegas 1
Mexico City 1
Milan 1
New York 1
Paris 1
Pescara 1
Redmond 1
Sanaa 1
Shenzhen 1
Swansea 1
Sydney 1
Warsaw 1
Wuxi 1
`Amir 1
Totale 482
Nome #
Electrospun hydroxyapatite-functionalized PLLA scaffold: potential applications in sternal bone healing 57
Atorvastatin treatment increases circulating endothelial progenitor cells in patients undergoing cardiopulmonary bypass surgery 57
Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation 56
Resynthesis of sternal dehiscence with autologous bone graft and autologous platelet gel 55
Near-infrared spectroscopy in adult cardiac surgery: between conflicting results and unexpected uses 52
Anthracycline Cardiotoxicity 51
Doxorubicinolone formation and efflux : A salvage pathway against epirubicin accumulation in human heart 51
Giant vegetation in prosthetic valve Candida albicans endocarditis 44
Dysphagia soon after off-pump coronary surgery: the single suture technique 42
In situ electrostimulation drives a regenerative shift in the zone of infarcted myocardium 41
Preoperative atorvastatin reduces bleeding and blood products use in patients undergoing on-pump coronary artery bypass grafting 40
A G-CSF releasing scaffold for stem cells seeding: a new differentiating device for cardiac purposes 39
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery 38
A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes 38
Heparin-releasing scaffold for stem cells: a differentiating device for vascular aims 37
Evaluation of ear function after cardiopulmonary bypass with otoacoustic emissions: a pilot study 37
Main risk factor in long-term postoperative aortic root enlargement after aortic valve surgery associated with ascending aorta replacement 35
Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure 32
Increase in circulating endothelial progenitor cells by atorvastatin treatment in patients undergoing cardiopulmonary bypass surgery 32
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. 31
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 30
Minimally Invasive Surgical Techniques in the Era of Hybrid Coronary Revascularization: Additional Benefits for the Elderly Patients? 28
Low dose anthracycline and risk of heart failure in a pharmacokinetic model of human myocardium exposure: analog specificity and role of secondary alcohol metabolites 26
Modeling human myocardium exposure to doxorubicin defines the risk of heart failure from low-dose doxorubicin 26
Natural "Y" venous graft for coronary revascularization 21
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model I Amrubicin accumulates to a lower level than doxorubicin or epirubicin 17
The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study 17
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin 17
The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: Insight to explain the cardiac safety of pixantrone in doxorubicin treated patients 16
Serum proteomics in patients with diagnosis of abdominal aortic aneurysm. 14
Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation 14
Heart rate variability: A new tool to predict complications in adult cardiac surgery 14
Simvastatin reduces CD40 expression in an experimental model of early arterialization of saphenous vein graft 12
Poly-L-lactic acid/hydroxyapatite electrospun nanocomposites induce chondrogenic differentiation of human MSC 12
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study). 12
Simvastatin attenuates the endothelial pro-thrombotic shift in saphenous vein grafts induced by Advanced glycation endproducts. 11
Pixantrone (PIX) Inhibition of Doxorubicinol (DOXOL) Formation in Human Myocardium: Implications for Cardiac Safety in Non-Hodgkin Lymphoma (NHL) Patients with Prior Anthracycline Treatment 11
Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass 9
null 5
Right coronary ostial aneurysm following a bentall procedure 3
Totale 1.180
Categoria #
all - tutte 14.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202264 0 3 0 0 0 0 0 7 0 0 0 54
2022/202314 2 0 0 0 1 0 0 0 0 2 6 3
2023/2024163 2 23 6 7 21 66 0 12 0 0 4 22
2024/2025939 33 12 66 7 11 28 13 5 93 162 509 0
Totale 1.180